APA (7th ed.) Citation

AN, L., SC, J., DW, S., JX, G., HL, L., M, Z., . . . G, W. (2026). Pharmacokinetics, efficacy, and safety of a novel aripiprazole microsphere-based long-acting injectable formulation for schizophrenia: A multicenter, randomized controlled trial. Journal of pharmaceutical analysis, 16(1), 101350. https://doi.org/10.1016/j.jpha.2025.101350

Chicago Style (17th ed.) Citation

AN, Li, et al. "Pharmacokinetics, Efficacy, and Safety of a Novel Aripiprazole Microsphere-based Long-acting Injectable Formulation for Schizophrenia: A Multicenter, Randomized Controlled Trial." Journal of Pharmaceutical Analysis 16, no. 1 (2026): 101350. https://doi.org/10.1016/j.jpha.2025.101350.

MLA (9th ed.) Citation

AN, Li, et al. "Pharmacokinetics, Efficacy, and Safety of a Novel Aripiprazole Microsphere-based Long-acting Injectable Formulation for Schizophrenia: A Multicenter, Randomized Controlled Trial." Journal of Pharmaceutical Analysis, vol. 16, no. 1, 2026, p. 101350, https://doi.org/10.1016/j.jpha.2025.101350.